![Fidelity US Momentum ETF](/common/images/company/NEO_FCMO.png)
Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and warrants" instead of "Exercise of stock options...
Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11...
Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2 of +1.1% vs. Q1 2021, impacted by the reduction in...
Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal...
Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de Deeply Subordinated Fixed to Floating Rate Bonds (ISIN...
Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs, unterstützen. Dazu wird Eurofins Genomics fünf...
Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé jamais mis en place au Royaume-Uni. Eurofins...
Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme. Eurofins Genomics will be genotyping five million...
Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.